What is Goldman Sachs' rating and price target for DuPont, and why did they assign a Neutral rating?

Goldman Sachs initiated coverage on DuPont de Nemours Inc. (NYSE:DD) with a Neutral rating and a $53.00 price target, stating that 'much of the stock's portfolio transformation benefit may already be reflected in its price.' This implies the firm believes the market has largely priced in the positive effects of DuPont’s strategic restructuring, leaving limited near-term upside potential to justify a more bullish stance.

How does Goldman Sachs forecast DuPont's segment-level growth, and how does it compare to the company's overall outlook?

Goldman Sachs forecasts 7% organic growth for DuPont's Healthcare & Water Technologies segment—significantly outpacing the company-wide organic growth forecast of 2%—while expecting the Diversified Industrials segment to grow in line with GDP through 2028. The firm also notes that DuPont's projected revenue and earnings growth for 2026–2028 ranks below its coverage average, reinforcing its cautious, Neutral stance.

Goldman Sachs Initiates DuPont Stock Coverage at Neutral on Growth

Jun 15, 2026

Goldman Sachs initiated coverage on DuPont with a Neutral rating and $53 price target, forecasting 7% organic growth for its Healthcare & Water Technologies segment through 2028.

Investing.com

Goldman Sachs Initiates DuPont Stock Coverage at Neutral on Growth

Investing.com Canada

2026-04-10

Eastman Kodak leverages materials science to drive growth beyond imaging

2026-04-14

Jim Fitterling capping decades-long career marked by transformation and turbulence

2026-04-14

FMC Corp. Stock (US3024913036): Is Its AgChem Competitive Edge Strong Enough to Unlock New Upside?

2026-04-22

DuPont Announces New 2035 Sustainability Goals